Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to test how safe and how well AST-120, an investigational
product, works in treating too much acid in the stomach. Patients will be randomly assigned
to one of two groups, AST-120 or a placebo for the first four weeks of the study. The
patients will be switched to the other group (AST-120 or placebo)for the following four
weeks.